Fmr LLC Purchases 25,407 Shares of Raymond James (RJF)

Share on StockTwits

Fmr LLC lifted its position in shares of Raymond James (NYSE:RJF) by 2.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 950,188 shares of the financial services provider’s stock after acquiring an additional 25,407 shares during the period. Fmr LLC owned 0.67% of Raymond James worth $70,705,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. CSat Investment Advisory L.P. grew its position in Raymond James by 86.5% in the 4th quarter. CSat Investment Advisory L.P. now owns 345 shares of the financial services provider’s stock valued at $26,000 after buying an additional 160 shares in the last quarter. Empire Life Investments Inc. grew its position in Raymond James by 3.1% in the 4th quarter. Empire Life Investments Inc. now owns 5,314 shares of the financial services provider’s stock valued at $395,000 after buying an additional 162 shares in the last quarter. Gateway Investment Advisers LLC grew its position in Raymond James by 2.4% in the 4th quarter. Gateway Investment Advisers LLC now owns 7,251 shares of the financial services provider’s stock valued at $540,000 after buying an additional 168 shares in the last quarter. Nissay Asset Management Corp Japan ADV grew its position in Raymond James by 1.8% in the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 10,252 shares of the financial services provider’s stock valued at $763,000 after buying an additional 181 shares in the last quarter. Finally, Captrust Financial Advisors grew its position in Raymond James by 41.1% in the 4th quarter. Captrust Financial Advisors now owns 748 shares of the financial services provider’s stock valued at $56,000 after buying an additional 218 shares in the last quarter. Institutional investors and hedge funds own 71.56% of the company’s stock.

NYSE:RJF opened at $87.80 on Monday. Raymond James has a twelve month low of $69.11 and a twelve month high of $102.17. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.12 and a quick ratio of 1.10. The stock has a market cap of $12.20 billion, a PE ratio of 13.57, a price-to-earnings-growth ratio of 0.70 and a beta of 1.55.

Raymond James (NYSE:RJF) last posted its quarterly earnings data on Wednesday, January 23rd. The financial services provider reported $1.79 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.73 by $0.06. Raymond James had a net margin of 12.79% and a return on equity of 15.86%. The company had revenue of $1.93 billion during the quarter, compared to analyst estimates of $1.92 billion. During the same quarter last year, the firm posted $1.61 EPS. The business’s revenue for the quarter was up 11.9% on a year-over-year basis. Equities research analysts expect that Raymond James will post 7.32 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 15th. Stockholders of record on Monday, April 1st will be given a dividend of $0.34 per share. The ex-dividend date is Friday, March 29th. This represents a $1.36 annualized dividend and a dividend yield of 1.55%. Raymond James’s dividend payout ratio (DPR) is 21.02%.

RJF has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of Raymond James from a “sell” rating to a “hold” rating in a research report on Monday, December 17th. Wells Fargo & Co decreased their target price on shares of Raymond James from $96.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, January 4th. Credit Suisse Group reduced their price objective on shares of Raymond James from $100.00 to $93.00 and set a “neutral” rating for the company in a research report on Monday, January 14th. Finally, ValuEngine upgraded shares of Raymond James from a “sell” rating to a “hold” rating in a research report on Wednesday, January 16th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $93.63.

TRADEMARK VIOLATION NOTICE: This report was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/4294194/fmr-llc-purchases-25407-shares-of-raymond-james-rjf.html.

Raymond James Profile

Raymond James Financial, Inc, a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments.

Featured Story: Dollar Cost Averaging

Institutional Ownership by Quarter for Raymond James (NYSE:RJF)

Receive News & Ratings for Raymond James Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raymond James and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Sabre Insurance Group  Stock Rating Reaffirmed by Numis Securities
Sabre Insurance Group Stock Rating Reaffirmed by Numis Securities
SSE  PT Lowered to GBX 1,050
SSE PT Lowered to GBX 1,050
Vectura Group  Earns Hold Rating from Peel Hunt
Vectura Group Earns Hold Rating from Peel Hunt
Critical Survey: Puhui Wealth Investment Managemnt  and Great Elm Capital
Critical Survey: Puhui Wealth Investment Managemnt and Great Elm Capital
Zacks Investment Research Downgrades Lumentum  to Sell
Zacks Investment Research Downgrades Lumentum to Sell
Innophos  Rating Lowered to C+ at TheStreet
Innophos Rating Lowered to C+ at TheStreet


© 2006-2019 Ticker Report